Research.Patient.info
Smoldering Multiple Myeloma research hub
2 indexed studies · 1 currently recruiting
- active not recruitingPHASE3
A Study of Subcutaneous Daratumumab Versus Active Monitoring in Participants With High-Risk Smoldering Multiple Myeloma
This study is looking at a new treatment called daratumumab for people with 'high-risk smoldering multiple myeloma' (SMM). It compares this treatment to simply monitoring the condition, to see if daratumumab can delay the disease getting worse.
United States · Argentina · Australia - recruitingPHASE2
Use of Elranatamab in Patients With High-risk Smoldering Multiple Myeloma
This study is looking at a new drug called Elranatamab for people with a condition called 'high-risk smoldering multiple myeloma'. We want to see how well it works and if it's safe to use in people who haven't had treatment before.
Finland · France · Greece